CoChat

Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome

Open access

The DOI matches its Crossref record; 88 of the 92 references it cites were found in a registry or an index; 22 of the 77 sources its claims cite were checked for support.

Abstract

Context: Late-night salivary cortisol (LNSC) measured by enzyme immunoassay (EIA-F) is a first-line screening test for Cushing syndrome (CS) with a reported sensitivity and specificity of >90%. However, liquid chromatography-tandem mass spectrometry, validated to measure salivary cortisol (LCMS-F) and cortisone (LCMS-E), has been proposed to be superior diagnostically. Objective, Setting, and Main Outcome Measures: Prospectively evaluate the diagnostic performance of EIA-F, LCMS-F, and LCMS-E in 1453 consecutive late-night saliva samples from 705 patients with suspected CS. Design: Patients grouped by the presence or absence of at least one elevated salivary steroid result and then subdivided by diagnosis. Results: We identified 283 patients with at least one elevated salivary result; 45 had an established diagnosis of neoplastic hypercortisolism (CS) for which EIA-F had a very high sensitivity (97.5%). LCMS-F and LCMS-E had lower sensitivity but higher specificity than EIA-F. EIA-F had poor sensitivity (31.3%) for adrenocorticotropic hormone (ACTH)-independent CS (5 patients with at least 1 and 11 without any elevated salivary result). In patients with Cushing disease (CD), most nonelevated LCMS-F results were in patients with persistent/recurrent CD; their EIA-F levels were lower than in patients with newly diagnosed CD. Conclusions: Since the majority of patients with ≥1 elevated late-night salivary cortisol or cortisone result did not have CS, a single elevated level has poor specificity and positive predictive value. LNSC measured by EIA is a sensitive test for ACTH-dependent Cushing syndrome but not for ACTH-independent CS. We suggest that neither LCMS-F nor LCMS-E improves the sensitivity of late-night EIA-F for CS.

Overview

CoChat Summary

TL;DR

In 1453 late-night saliva samples from 705 patients with suspected Cushing syndrome, EIA cortisol (EIA-F) was highly sensitive for ACTH-dependent Cushing syndrome but had poor specificity and positive predictive value. LC-MS/MS cortisol and cortisone did not improve sensitivity and were less sensitive than EIA-F for ACTH-dependent disease, while all assays performed poorly for ACTH-independent adrenal Cushing syndrome.

Key findings

  • Among 40 patients with ACTH-dependent Cushing syndrome, EIA-F had sensitivity 97.5%, specificity 69.3%, PPV 16.8%, and NPV 99.8%; LCMS-F had sensitivity 67.5% and specificity 84.6%; LCMS-E had sensitivity 92.5% and specificity 76.2%.
  • For ACTH-independent adrenal Cushing syndrome (16 patients: 5 with ≥1 elevated salivary steroid and 11 without), EIA-F sensitivity was 31.3%, LCMS-F 25.0%, and LCMS-E 18.8%; PPVs were 2.5%, 4.0%, and 2.0%, respectively.
  • In 35 patients with Cushing disease, false-negative results below assay cutoffs occurred in 12/35 (34%) by LCMS-F, 3/35 (9%) by LCMS-E, and 1/35 (3%) by EIA-F; most nonelevated LCMS-F results were in patients with persistent/recurrent disease.
  • Of 283 patients with at least one elevated salivary result, only 45 had proven Cushing syndrome; 238 did not have proven CS, and most false-positive results were by EIA-F.

Methods

  • Prospective collection of 1453 consecutive late-night salivary samples from 705 patients ordered as clinical care at Wisconsin Diagnostic Laboratories during calendar year 2019; samples were tested by FDA-cleared EIA-F and by LC-MS/MS for cortisol (LCMS-F) and cortisone (LCMS-E).
  • Patients were grouped by presence or absence of at least one elevated salivary steroid result using cutoffs EIA-F ≥3.3 nmol/L, LCMS-F ≥2.8 nmol/L, and LCMS-E ≥8.7 nmol/L; all 283 patients with any abnormal result and 121 randomly selected patients with all normal results underwent in-depth medical record review.
  • Diagnostic performance was calculated with MEDCALC; continuous data were compared by Mann-Whitney rank sum or Kruskal-Wallis tests and categorical data by chi-square, with P < 0.05 considered significant.

Limitations

  • The paper states it did not address the reasons for clinical suspicion of CS, so pretest probability could not be evaluated; it also notes dependence on cutoffs established contemporaneously in healthy subjects and that results close to any cutoff require clinical context.
  • The paper states the study is limited by the relatively small number of patients, particularly for conclusions about recurrent Cushing disease.
  • Evident from the text: this was a single-center study, and 20 of 31 patients without elevated salivary results could not be evaluated because extramural medical records were unavailable.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1210/jendso/bvaa107

Cites

88 of 88 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1. Flow chart showing late-night salivary samples and associated patients in the study.
Figure 1. Flow chart showing late-night salivary samples and associated patients in the study.CC BY-NC-ND · PubMed Central
Figure 2. Late-night salivary enzyme immunoassay cortisol (EIA-Cortisol), liquid chromatography-tandem mass spectrometry (LCMS) cortisol and cortisone, and the ratio of LCMS cortisol to cortisone in 35 patients with Cushing disease compared with the 121 patients randomly chosen with all normal salivary steroid results and without the diagnosis of Cushing syndrome of any type. Horizontal line is the median; box indicates 25th to 75th percentile, whisker indicates 10th and 90th percentiles, and outliers are indicated by circles. P values are from Mann-Whitney Rank Sum tests.
Figure 2. Late-night salivary enzyme immunoassay cortisol (EIA-Cortisol), liquid chromatography-tandem mass spectrometry (LCMS) cortisol and cortisone, and the ratio of LCMS cortisol to cortisone in 35 patients with Cushing disease compared with the 121 patients randomly chosen with all normal salivary steroid results and without the diagnosis of Cushing syndrome of any type. Horizontal line is the median; box indicates 25th to 75th percentile, whisker indicates 10th and 90th percentiles, and outliers are indicated by circles. P values are from Mann-Whitney Rank Sum tests.CC BY-NC-ND · PubMed Central
Figure 3. Number of Cushing disease patients (N = 35) with late-night EIA-Cortisol and LC-MS/MS cortisol and cortisone equal to or below (Normal) or above (Abnormal) the reference range for that assay [26]. P values are from chi-square analysis.
Figure 3. Number of Cushing disease patients (N = 35) with late-night EIA-Cortisol and LC-MS/MS cortisol and cortisone equal to or below (Normal) or above (Abnormal) the reference range for that assay [26]. P values are from chi-square analysis.CC BY-NC-ND · PubMed Central
Figure 4. Number of Cushing disease patients with de novo Cushing disease (N = 12) and patients with recurrent/persistent Cushing disease (N = 23) with late-night EIA-Cortisol and LC-MS/MS cortisol and cortisone equal to or below (Normal) or above (Abnormal) the reference range for that assay [26]. P values indicate comparison of LC-MS/MS cortisol vs other 2 analytes.
Figure 4. Number of Cushing disease patients with de novo Cushing disease (N = 12) and patients with recurrent/persistent Cushing disease (N = 23) with late-night EIA-Cortisol and LC-MS/MS cortisol and cortisone equal to or below (Normal) or above (Abnormal) the reference range for that assay [26]. P values indicate comparison of LC-MS/MS cortisol vs other 2 analytes.CC BY-NC-ND · PubMed Central
Figure 5. Correlation of salivary steroid measurements vs salivary transferrin concentrations in 39 patients from Table 6. There were no significant correlations found.
Figure 5. Correlation of salivary steroid measurements vs salivary transferrin concentrations in 39 patients from Table 6. There were no significant correlations found.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

16 Valid · 2 Not valid · 15 Not checked · 79 Own results and interpretations

64 more claims · 4 with their cited sources checked

Create a free account to see all 112 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 16
  • It may state two separate claims as one. 28

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 88 references

Cited by

See all 36

Metadata

Authors
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H.
Affiliations
  • Medical College of Wisconsin (US)
  • Aurora St. Luke's Medical Center (US)
Corresponding author
Raff, Hershel
Venue
Journal of the Endocrine Society
Published
2020-07-24
Volume
4
Issue
10
Pages
bvaa107-bvaa107
ISSN
2472-1972 (ISSN-L)
OpenAlex
W3044928262
Cited by
36
References
92
Citations by year
2026: 4 · 2025: 4 · 2024: 5 · 2023: 10 · 2022: 5 · 2021: 7 · 2020: 1
FWCI
4.34
Type
journal article
Language
en
Open access
Locations
  • Journal of the Endocrine Society (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Advocate Aurora Research Institute
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
Keywords
Cushing's syndrome, late-night salivary cortisol, salivary cortisone, enzyme immunoassay, liquid chromatography-tandem mass spectrometry, diagnostic accuracy, Cushing's disease, ACTH-independent Cushing's syndrome, screening sensitivity and specificity

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome. https://app.cochat.ai/papers/10.1210/jendso/bvaa107
The paper
Kannankeril, J., Carroll, T., Findling, J. W., Javorsky, B., Gunsolus, I. L., Phillips, J., & Raff, H. (2020). Prospective Evaluation of Late-Night Salivary Cortisol and Cortisone by EIA and LC-MS/MS in Suspected Cushing Syndrome. Journal of the Endocrine Society. https://doi.org/10.1210/jendso/bvaa107

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.